Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AER funds

This article was originally published in The Tan Sheet

Executive Summary

Trade groups call for "at least $3 mil. to help bolster the monitoring of adverse events associated with dietary supplements" in May 30 letter to House Appropriations/Agriculture subcommittee Chair Henry Bonilla (R-Tex.). CHPA, NNFA, CRN and UNPA note "one consequence of the increasing use of nutritional supplements by consumers is that FDA's system for processing [AERs] needs to be modernized." Funding for system improvements may have a better shot with Sen. Tom Harkin (D-Iowa) gaining seniority on corresponding Senate panel as Democrats take control of upper house (1"The Tan Sheet" May 28, p. 18)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092609

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel